Recent Advancement of Nanotheranostics in Cancer Applications
- PMID: 38812425
- DOI: 10.2174/0115672018307617240514092110
Recent Advancement of Nanotheranostics in Cancer Applications
Abstract
The field of nanomedicine shows promising implications in the concurrent delivery of therapeutic and diagnostic (theranostics) compounds in a single platform. Nanotheranostics is incredibly promising since it offers simultaneous non-invasive disease detection and treatment together with the exciting ability to track drug release and distribution in real-time, thereby forecasting and evaluating the efficacy of the therapy. The cancer theranostic approach improves the cancer prognosis safely and effectively. Common classes of nanoscale biomaterials, including magnetic nanoparticles, quantum dots, upconversion nanoparticles, mesoporous silica nanoparticles, carbon- based nanoparticles, and organic dye-based nanoparticles, have demonstrated enormous potential for theranostic activity. The need for improved disease detection and enhanced chemotherapeutic treatments, together with realistic considerations for clinically translatable nanomaterials will be key driving factors for theranostic agent research shortly. The developments of precision theranostic nanomaterials are employed in imaging systems like, MRI, PET, and SPECT with multifunctional ability. In this review, different nanoparticles/nanomaterials that are used/developed for theranostic activity are discussed.
Keywords: Nanotheranostics; QDs; cancer drug delivery; imaging; photosensitizer.; upconversion nanoparticles.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Advanced Functional Nanomaterials for Theranostics.Adv Funct Mater. 2017 Jan 12;27(2):1603524. doi: 10.1002/adfm.201603524. Epub 2016 Nov 7. Adv Funct Mater. 2017. PMID: 28824357 Free PMC article.
-
Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.Molecules. 2022 Dec 7;27(24):8659. doi: 10.3390/molecules27248659. Molecules. 2022. PMID: 36557793 Free PMC article. Review.
-
Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer.Nanotheranostics. 2018 Jan 1;2(1):70-86. doi: 10.7150/ntno.21638. eCollection 2018. Nanotheranostics. 2018. PMID: 29291164 Free PMC article. Review.
-
Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis.ACS Appl Mater Interfaces. 2014 Dec 24;6(24):21859-73. doi: 10.1021/am5036225. Epub 2014 Jul 22. ACS Appl Mater Interfaces. 2014. PMID: 25014486 Free PMC article. Review.
-
Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities.Asian J Pharm Sci. 2021 Jan;16(1):24-46. doi: 10.1016/j.ajps.2020.03.003. Epub 2020 May 12. Asian J Pharm Sci. 2021. PMID: 33613728 Free PMC article. Review.
Cited by
-
Nanomedicine for cancer patient-centered care.MedComm (2020). 2024 Oct 20;5(11):e767. doi: 10.1002/mco2.767. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39434967 Free PMC article. Review.
-
Harnessing nanotechnology for cancer treatment.Front Bioeng Biotechnol. 2025 Jan 20;12:1514890. doi: 10.3389/fbioe.2024.1514890. eCollection 2024. Front Bioeng Biotechnol. 2025. PMID: 39902172 Free PMC article. Review.
LinkOut - more resources
Full Text Sources